- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 106746, 4 pages
Cytotoxicity of Selected Medicinal and Nonmedicinal Plant Extracts to Microbial and Cervical Cancer Cells
1Department of Plant and Wildlife Sciences, Brigham Young University, Provo, UT 84602, USA
2The New York Botanical Garden, 200th Street and Kazimiroff Boulevard, Bronx, NY 10458-5126, USA
Received 2 August 2011; Accepted 16 December 2011
Academic Editor: Ikhlas A. Khan
Copyright © 2012 Gary M. Booth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This study investigated the cytotoxicity of 55 species of plants. Each plant was rated as medicinal, or nonmedicinal based on the existing literature. About 79% of the medicinal plants showed some cytotoxicity, while 75% of the nonmedicinal plants showed bioactivity. It appears that Asteraceae, Labiatae, Pinaceae, and Chenopodiaceae were particularly active against human cervical cancer cells. Based on the literature, only three of the 55 plants have been significantly investigated for cytotoxicity. It is clear that there is much toxicological work yet to be done with both medicinal and nonmedicinal plants.
There is a one-in-four chance that a drug used from any pharmacy has an active ingredient derived from a plant . Indeed, the international consumer market for medicinal herbs and botanicals is estimated to be at about US $18 billion . Hence, in our technological age, plants continue to play a significant role both medically and economically.
Even the most ancient written records of human civilization tell of humans using plants in everyday life. For centuries plants have been used to feed, clothe, and heal families. Examples of medicine that contains plant derivatives include aspirin, used for pain relief and inflammation reduction; physostigmine and pilocarpine, used for glaucoma control; quinidine, which has saved the lives of many heart attack victims.
The principal goal of this study was to determine if extracts from selected medicinal and nonmedicinal plants were cytotoxic; often, the difference between a therapeutic and a toxic extract or compound is simply the dose level. Our hope is that these survey data can be used as early indicators of some plants that may have therapeutic activity. Moerman has done extensive screening studies on a variety of medicinal plants . From his investigation, we selected 55 plants representing 37 different species from 8 families. The four principal families, Asteraceae, Labiatae, Ranunculaceae, and Pinaceae, represent the first, third, fourth, and fifth families with the most medicinal species. It was hoped that our data might show some trends of toxicity within medicinally rich families.
The toxicity of each extract was determined in both prokaryotic and eukaryotic cells. Prokaryote cells included Staphylococcus aureus, a gram-positive cocci responsible for infections of the skin and respiratory tract, food poisoning, and toxic shock; Salmonella choleraesuis, a gram-negative facultative aerobe responsible for food poisoning; Pseudomonas aeruginosa, a gram-negative rod that causes infections in wounds. For the eukaryotic system, HeLa cells, an epithelial carcinoma of the cervix, were used.
2. Materials and Methods
2.1. Plant Extraction(i)50 g of plant tissue were collected and dried at 45°C.(ii)The plant was ground in a Wiley Model no. 4 plant mill.(iii)The ground material was then extracted in methanol for twenty-four hours.(iv)The samples were filtered in glass-fiber filters fitted with coarse pore discs, and rotary evaporated down to 20 mL of extract on a Buchi RE111 Rotary Evaporator.
2.2. Microbial Bioassay(i)Twenty-four hours before the assay, each of the three bacteria were grown in a culture tube with 5 mL of tryptic soy broth without dextrose and incubated at 35°C.(ii)(14.5 cm) Petri dishes were previously prepared with a coat of Muller Hinton Medium (agar). The cultures were checked on a spectrophotometer to ensure the proper growth (20% transmittance at 600 nm). A lawn was then spread in the petri dish. Six 1.4 cm circles of filter paper were then coated in plant extract, three with 20 μL and three with 30 μL, and placed on the plate. A disk with 20 μL of water was added to the plate for a negative control and to S. aureus, S. choleraesuis, 10 μL of Ampicillin (BBL Sensi-Disc (Becton Dickinson)) was added as a positive control. The plates were incubated overnight at 35°C.(iii)The plates were then collected the next day and the zones of inhibition were measured.
2.3. HeLa Assay(i)HeLa cells were maintained and assayed in MEM with α modification (Sigma M-0894) supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 1x MEM-nonessential amino acids (Sigma M-7145), 2 mM L-glutamine, and gentamicin at 50 μg/mL.(ii)Each extract was dried down and 2 mg/mL solutions were made using 10 mM Tris buffer at pH 7.4.(iii)150 μL of a solution of suspended HeLa cells diluted with 15 mL of α-MEM is added to each well of a 96 well plate and incubated overnight at 37°C and 5% CO2.(iv)The next day 75 μL, 50 μL, 25 μL with 25 μL of α-MEM, 12.5 μL with 37.5 μL of α-MEM, or 6 μL with 44 μL of α-MEM of the 2 mg/mL extracts was added to 9 wells as a control. The prepared plate was incubated overnight.(v)The cells were arrested the next morning with 0.4 N perchloric acid. The perchloric acid is removed, and the cells were stained in 4% sulforhodamine B in 1% acetic acid and then washed in 1% acetic acid. The dye was allowed to dry and 150 μL of 10 mM Tris base unbuffered was then added to each well, and the absorbance of each well was read using a spectrophotometer at 570 nm.(vi)The percent viability was calculated as the ratio of absorbance of the treated sample over the average of the controls. These values were then plotted and analyzed for a dose response.
3.1. Microbial Assay
Of the 55 plants tested, only four, Pinus monticola, Abies procera, Salvia vaseyi, and Salvia apiana, inhibited the growth of S. aureus. The remaining microorganisms were unaffected by the extracts. However, the zones of inhibition were quite small, only about 1 cm each. The assay is rather a crude test when compared with the HeLa cell assay. This is understandable because the zone of inhibition is directly proportional to the concentration of the biologically active agent and its diffusibility, so the possibility of active compounds not showing a positive response could be expected if the active ingredients did not diffuse. Due to the screening nature of this procedure and small sample size, the quantitative analysis of the size of the rings of inhibition was quite subjective.
3.2. HeLa Cell Assay
The LC-50 s were calculated for each of the samples. Some of the extracts were so toxic to the HeLa cells that very low doses of 0.0l and 0.001 mg/mL were studied in order to establish an LC-50. The LC-50 s were calculated from least squares regression using the LINEST function on Microsoft Excel 2000 over the dose response range or the whole data set in the case of nontoxic extracts to get a rough quantitative value in order to assess cytotoxicity. Tris buffer, the control, gave an average 92% viability with no dose response. All values were adjusted up by 8% accordingly.
We experienced four general trends in the data. The first two types we labeled “A” for active. The first type was a clear dose-response over the full range of concentrations. Type two followed a steep dose-response over the initial range of concentrations while the lower concentrations did not. Type two was the most cytotoxic. Type three was labeled with an “M” for mildly active. These showed a weaker dose-response only at the higher concentrations. Type four was labeled “N” for not active. These samples showed no dose response and only marginal mortality. These trends were then evaluated over medicinal and family lines (Table 1).
4. Discussion and Conclusions
Of the 46 medicinal plant extracts, 54% were active, 26% were mildly active, and 20% were not active against HeLa cells. Thus, 80% of the medicinal plant extracts showed some type of cytotoxicity. This strongly suggests that there may be some connection between plants known from indigenous cultures to have medicinal properties compared to empirically determined cytotoxicity. Our eight non-medicinal plants also tended to be bioactive, with 50% active, 13% mildl, and 37% not active. Only four samples showed antibacterial activity, which was only in S. aureus, and all these extracts were from medicinal plants. Thus, only 14% of the medicinal plants showed limited antibiotic activity.
Asteraceae, the sunflower family and one with the highest medicinal activity rating in Moerman’s paper , was the only family from which we had a fairly large sample, 15 medicinal plants. Extracts from Asteraceae tended to be quite active and followed the general trends of medicinal plant bioactivity as stated above with 54% active, 29% mildly active, and 17% not active. The mint family, Labiateae, also tended to be cytotoxic with 86% of the plants showing bioactivity. Because only seven plants were tested, more data should be collected from this family before a general conclusion can be made about its cytotoxicity. Of the nine Pinaceae plant extracts, 67% showed some bioactivity. Additional work is needed to determine which plant parts tend to have the highest bioactivity. The least active of our five medicinal families was Ranunculaceae with two out of six plant extracts (33%) showing mild activity. Overall these data clearly suggest that non-medicinal as well as so-called medicinal plants should be used in general cytotoxicity screening evaluations. In fact, de Oliveira Maria et al.  also found significant bioactivity in 12 species of Amazonian plants which were non-medicinal.
Though this work proved to be insightful, future studies should be undertaken in order to get a clearer picture of the evolutionary relationship of bioactivity and medicinal ranking of plants. From the literature, it appears that only three plants from our group, Ambrosia ambrosioides [5, 6], Gutierrezia microcephala , and Atriplex confertifolia  have had extensive research on their cytotoxicity. Hence, there is a great deal of toxicology work yet to be done on the remainder of the plants shown to be bioactive in our investigation.
The author would like to thank Jeff Nackos, Nathan Ruben, Eric Jacobsen, and Malia Price for their work on the project; the staff of Dr. Leo Vernon’s laboratory for their help with the HeLa cell assay; the New York Botanical Garden for providing the extracts; Brigham Young University for supplying personnel and resources.
- M. J. Balick and P. A. Cox, Plants, People and Culture: The Science of Ethnobotany, Scientific American Library, New York, NY, USA, 1996.
- B.-E. van Wyk and M. Wink, Medicinal Plants of the World Portland, Timber Press, London, UK, 2004.
- D. E. Moerman, “The medicinal flora of Native North America: an analysis,” Journal of Ethnopharmacology, vol. 31, no. 1, pp. 1–42, 1991.
- V. de Oliveira Maria, B. A. Carneiro Lucia, B. de Cauper, G. Socoiro, and A. Martin, “In vitro screening of Amazonian plants for hemolytic activity and inhibition of platelet aggregation in human blood,” Acta Amazonica, vol. 39, no. 4, pp. 973–980, 2009.
- R. W. Doskotch and C. D. Hufford, “Damsin, the cytotoxic principle of Ambrosia ambrosioides (Cav.) Payne,” Journal of Pharmaceutical Sciences, vol. 58, no. 2, pp. 186–188, 1969.
- R. W. Doskotch and C. D. Hufford, “The structure of damsinic acid, a new sesquiterpene from Ambrosia ambrosioides () Payne,” Journal of Organic Chemistry, vol. 35, no. 2, pp. 486–490, 1970.
- X.-P. Dong, C.-T. Che, and N. R. Farnsworth, “Cytotoxic flavonols from Gutierrezia microcephala,” Journal of Natural Products, vol. 50, no. 2, pp. 337–338, 1987.
- C. J. Capua, N. P. Hopson, C. M.M. Stewart et al., “Cytotoxicity of atriplex confertifolia,” Journal of Toxicology, vol. 2010, Article ID 976548, 2010.